Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FK273
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,404
Award facts
- Contract value 100% obligated
- $34,403.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,403.99 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pens on November 6, 2025, with a completion date of November 7, 2025. This is a firm fixed price, non-set-aside delivery order performed at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support agreement running through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company has demonstrated capability to compete successfully for federal pharmaceutical contracts across multiple therapeutic domains, with a portfolio encompassing specialty medications, brand-name and generic drugs, and medical supplies. This delivery order for Dupixent, a biologic medication used in the treatment of allergic and immunologic conditions, reflects the company's ongoing role in supplying specialized pharmaceutical products to support military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FK273?
SPE2DR26FK273 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FK273 worth?
The government has obligated $34,404 on SPE2DR26FK273.
Is contract SPE2DR26FK273 an order under another contract?
Yes. SPE2DR26FK273 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK273 competed?
The extent of competition for SPE2DR26FK273 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award